NCT06120504 2026-01-26A Safety Study of PF-08046045/SGN-35T in Adults With Advanced CancersSeagen Inc.Phase 1 Terminated22 enrolled
NCT03432741 2025-05-26Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerMayo ClinicPhase 1 Terminated17 enrolled